Back

PARADISE-MI - event rates and treatment effect of sacubitril/valsartan v ramipril by the presence or absence of transient pulmonary congestion and/or LVEF less or greater than 40

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Complicated acute coronary syndromes issues Postinfarction Period ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Mark C Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Prognostic impact of plasma glucose on cardiogenic shock patients with or without diabetes ellitus: smart rescue trial
Doctor S. Choi (Incheon, KR)
Abstract Slides
Presentation thumbnail
Temporal trend mortality and in-hospital mortality predictors in an ischemic cardiogenic shock population: a 10 years single-centre retrospective study.
Doctor L. Belfioretti (Ancona, IT)
Abstract Slides
Presentation thumbnail
Cardiac rupture after ST elevation myocardial infarction - a decade s experience of a tertiary cardiology centre
Doctor C. Margineanu (Bucharest, RO)
Abstract Slides
Presentation thumbnail
One-year unplanned readmission after percutaneous coronary intervention in ST-elevation myocardial infarction: rates, causes and predictors
Doctor O. Alkhalaila (Doha, QA)
Abstract Slides
Presentation thumbnail
Deterioration of cardiogenic shock after acute myocardial infarction defined by the society for cardiovascular angiography and intervention cardiogenic shock classification scheme
Doctor T. Mukaida (Osaka, JP)
Abstract Slides

Access the full session

Session thumbnail
Complicated acute coronary syndromes issues

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources